Blog & Commentary
Simmons Hanly Conroy’s support blog is a place for clients and families to find news, education, and inspirational stories about the following areas of litigation: mesothelioma and asbestos, dangerous drugs and devices, consumer protection and mass torts, personal injury and environmental litigation.
Blog
C.R. Bard Reaches Settlement in Second Lawsuit Trial Over its Transvaginal Mesh Product
C.R. Bard, a medical technologies developer, manufacturer and marketer commonly referred to simply as Bard, has reached a settlement in the second lawsuit trial of the multidistrict litigation for its transvaginal mesh… Read More
Get the Kids Involved in Miles for Meso This Year
The Miles for Meso 5K isn’t just a race. The event will have multiple activities for the whole family, including the kids. When families come to the Miles for Meso event in… Read More
Asbestos Exposure in the UK
Asbestos exposure is a serious issue throughout the United States – however, it’s also a problem in other countries, including the UK. Even though the United Kingdom banned asbestos use years ago,… Read More
How to Get Involved in Miles for Meso This Year
There are several Miles for Meso events, nationally sponsored by the Firm, that recognize Mesothelioma Awareness Day on September 26. The events promote efforts to raise money for mesothelioma research, ban asbestos… Read More
Become a Sponsor for the 2013 Miles for Meso
The Firm’s Miles for Meso 5K event will be held in Alton, Illinois on Sat., Sept. 21, 2013. This year marks the fifth anniversary of the race, and approximately 1,000 people are… Read More
Moldy Washing Machines Could Influence Future of Class Action Lawsuits
A recent Slate article titled, “The Case of the Moldy Washing Machines” by Emily Bazelon, gives an overview of the legal and consumer protection implications of a class action case that visited the Supreme Court… Read More
Miles for Meso Race to Take Place September 21, 2013
Early registration is now open for the Alton, Illinois Miles for Meso 5K Race & 2K Fun Run/Walk. The race will begin at Simmons Hanly Conroy Building at One Court Street on… Read More
Roche Halts Development of New Diabetes Drug Due to Safety Concerns
Swiss pharmaceutical giant Roche has stopped further development of its new diabetes drug called aleglitazar. This decision could increase safety concerns for drugs similar to aleglitazar, including the controversial medication called Avandia.… Read More
Asbestos and Mesothelioma Updates: July 2013
The mesothelioma lawyers at the Firm are committed to keeping you up-to-date on the latest asbestos and mesothelioma headlines. Browse recent headlines highlighting the dangers of asbestos exposure and new information… Read More
Advertising Nets Lipitor Better Sales Despite Dangerous Side Effects, Generic Competition
Pharmaceutical company Pfizer’s lucrative cholesterol drug Lipitor is expected to generate approximately $3 billion in revenue by 2015, according to a recent report by AARP’s Public Policy Institute. The cholesterol medication is… Read More